Fresh analysis suggests that patients who discontinue new weight-loss injections like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who halt traditional lifestyle programs.
Published data in a leading health publication points out that while overweight people frequently drop a large proportion of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying such drugs must be informed of the danger of rapid weight regain when the treatment concludes," cautioned expert Dr. Susan Jebb.
This pace of regain means a return to pre-treatment weight in about one and a half years.
Analyzing Approaches
The study, which examined 37 of trials involving thousands of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Scientists emphasize that individuals who lose weight through dieting generally have a less rapid creep back—around 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Experts propose the way of the jabs explains the accelerated rebound.
The injections mimic a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication leads to hunger is no longer kept in check, making binge eating far more likely."
An Ongoing Issue?
Medical guidelines suggest the jabs for people with obesity-related health risks, alongside recommended diet and exercise modifications.
Professionals contend that, considering the high risk of relapse, the therapy should be considered ongoing.
This perspective is supported by pharmaceutical companies, who state that the results "emphasize the long-term nature of excess weight," similar to managing conditions like high blood pressure.
Patient Testimonies
Individuals who have discontinued the medication explain a intense resurgence of cravings.
"I experienced a switch activating and you're instantly ravenous," described a patient.
The struggle is exacerbated if users have not developed sustainable dietary or behavioural modifications during therapy.
Widespread Interest
Figures suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire remaining high.
- Adoption is higher among females compared to men.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
Finally, experts caution that while the jabs are potent tools for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on ongoing behavioural changes.
